Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis

Nahum Méndez-Sánchez; E. Cerda-Reyes; Fátima Higuera-de-la-Tijera; Ana K. Salas-García; Samantha Cabrera-Palma; Guillermo Cabrera-Álvarez; Carlos Alejandro Cortez-Hernández; Luis A Pérez-Arredondo; Emma Purón-González; Edgar Coronado-Alejandro; Oscar Ramírez-Pérez; Alfonso Vera-Barajas

doi:https://doi.org/10.12688/f1000research.21918.1

doi.org/10.12688/f1000research.21918.1

Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis

,

,

..., Alfonso Vera-Barajas

5

F1000Research

Volume: 9, Pages: 56 - 56

Published: Jan 28, 2020

Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is a serious worldwide health problem, with an estimated global prevalence of 24%; it has a notable relationship with other metabolic disorders, like obesity and type 2 diabetes mellitus (T2DM). Nonalcoholic steatohepatitis (NASH) is one of the most important clinical entities of NAFLD, which is associated with an increased risk of progression to liver cirrhosis and...

Paper Fields

Paper Details

Title

Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis

DOI

doi.org/10.12688/f1000research.21918.1

Published Date

Jan 28, 2020

Journal

F1000Research

Volume

9

Pages

56 - 56

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History